StockData
Grifols SA logo

Grifols SA (GIKLY) stock

GIKLYOTCPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GRFS
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30
$5.55+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.91BP/E 4.2Yield –

Earnings

Grifols's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Grifols's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Grifols has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Grifols puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Grifols filed with the SEC as exhibits to Form 8-K or 6-K

  1. GRIFOLS TO ACQUIRE TALECRIS BIOTHERAPEUTICS CREATING A WORLD
    6-K
  2. Creating a world leading integrated plasma company
    6-K
  3. GRIFOLS TO ACQUIRE TALECRIS CREATING A WORLD LEADING COMPETITOR IN THE PRODUCTION OF LIFE-SAVING
    6-K

See a number that looks wrong?